vimarsana.com
Home
Live Updates
ModernaTX, Inc: Moderna Reports First Quarter 2023 Financial
ModernaTX, Inc: Moderna Reports First Quarter 2023 Financial
ModernaTX, Inc: Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates
First quarter 2023 revenues of $1.9 billion; GAAP net income of $79 million and GAAP diluted EPS of $0.19Company in negotiations for new orders for fall of 2023 in U.S., Japan, and EU, in addition to reiterating
Related Keywords
Japan ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
United States ,
Australia ,
American ,
Chris Ridley ,
Lavina Talukdar ,
Research Development ,
American Society Of Gene Cell Therapy ,
Moderna Inc ,
Corporate Development ,
Group Purchasing Organizations Gpos ,
Centers For Disease ,
Department Of Defense ,
Exchange Commission ,
Company Accolades ,
Development Expenses ,
Nasdaq ,
Moderna Inc View ,
American Association For Cancer Research ,
Advanced Purchase ,
Advance Purchase Agreements ,
Chief Executive Officer ,
Southern Hemisphere ,
Northern Hemisphere ,
American Association ,
Cancer Research ,
Open Label Extension ,
American Society ,
Cell Therapy ,
Life Edit ,
Administrative Expenses ,
Per Share ,
Disease Control ,
Group Purchasing Organizations ,
Physician Buying Groups ,
Moderna Direct ,
Vaccines Day ,
Purchase Agreements ,
South San Francisco ,
Generation Bio ,
Life Edit Therapeutics ,
Oriciro Genomics ,
Great Place ,
Analyst Event ,
Months Ended March ,
Ended December ,
Private Securities Litigation Reform Act ,
Annual Report ,
Vice President ,
Inc View ,
Modernatx ,
Moderna ,
Reports ,
First ,
Quarter ,
023 ,
Financial ,
Results ,
Rovides ,
Business ,
Updates ,